Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
12,801 total articles
Ming Shing Group Holdings Limited announced entering into a stock purchase agreement to acquire PMA Nano Carbon Tech Limited for $110 million through issuing convertible promissory notes. This acquisition aims to expand Ming Shing's portfolio into graphene-based thermal management technologies with applications across AI hardware cooling, new energ…
Structure Therapeutics announced participation in two major healthcare investor conferences in June 2026 to discuss its development of novel oral small molecule therapeutics targeting metabolic diseases such as obesity. Management will deliver presentations and conduct meetings, with webcasts accessible online.
Pool Corporation, the largest wholesale distributor of swimming pool and backyard products, announced its participation in several investor conferences throughout June 2026 to engage with the investment community and present its growth strategy.
Assembly Biosciences has completed a registered public offering of approximately 3.9 million common shares and 415,000 pre-funded warrants, raising gross proceeds of $115 million. The company plans to use the funds to advance clinical development of its therapeutic candidates targeting serious viral and liver diseases and for general corporate purp…
Zscaler Inc. announced its Q3 fiscal 2026 results with revenue and ARR growth of 25% YoY, record profitability with non-GAAP operating margin at 23%, and strong cash flow performance. The company highlighted strategic moves targeting AI-driven cybersecurity enhancements, including acquisitions and partnerships. Guidance for fiscal 2026 was raised, …
Kailera Therapeutics announced its first quarter 2026 financial results and clinical updates highlighting significant progress across four obesity-focused clinical-stage drug programs. The company initiated five late-stage global trials including the Phase 3 KaiNETIC program for ribupatide injection and reported positive topline data from partner H…
Apogee Therapeutics will report Part B 16-week data from the Phase 2 APEX trial of zumilokibart, a novel biologic targeting moderate-to-severe atopic dermatitis (AD), on May 27, 2026, followed by a webcast and conference call. The company aims to advance treatments in inflammatory and immunology markets with optimized antibody therapies, addressing…
Dianthus Therapeutics, a clinical-stage biotech specializing in therapies for severe autoimmune diseases, announced participation in the Jefferies Global Healthcare Conference and Goldman Sachs Global Healthcare Conference in June 2026 with executive-led fireside chats and investor meetings.
Firefly Aerospace has secured a $75 million subcontract from NASA's Jet Propulsion Laboratory to deliver four drones to the Moon's south pole as part of NASA's MoonFall mission, aiming for launch no earlier than 2028. The mission supports NASA's long-term lunar exploration and infrastructure goals under the Artemis program. Firefly will utilize its…
NMI Holdings, Inc. announced that its President and CEO, Adam Pollitzer, will participate in Moody's US Housing Executive Series broadcast on May 28, 2026. The event will cover topics related to the housing market, aligning with NMI's role in mortgage insurance.
Peace Acquisition Corp successfully completed its initial public offering of 6 million units at $10 each, raising $60 million. The company, listed on Nasdaq under ticker PECEU, is a blank check acquisition firm focusing on business combinations within Asia, excluding Mainland China, Hong Kong, and Macau. Funds raised are held in trust as the compan…
Arcutis Biotherapeutics, a commercial-stage immuno-dermatology company, announced its management will present at the Goldman Sachs 47th Annual Global Healthcare Conference in Miami from June 8-10, 2026. The presentation includes a fireside chat scheduled for June 9, which will be webcast and archived on the company's website for 180 days. Arcutis f…
Molecular Partners AG, a clinical-stage biotech company developing DARPin therapeutics, announced its management team's participation in the TD Cowen 7th Annual Oncology Innovation Summit. The event includes a fireside chat and will be webcast, providing the company an opportunity to showcase its innovative protein drug platform and ongoing clinica…
Toll Brothers, a leading US luxury home builder, announced the grand opening of amenities at their new Cross Kirkland Towns community in Kirkland, Washington. The event invites prospective buyers to explore the community's features, including model homes and recreational facilities. The development features luxury townhomes with modern design and c…
Brunswick Corporation announced it has earned 15 Boating Industry Magazine Top Product Awards for 2026, the highest number it has received in a single year. The awards span 13 different Brunswick brands and recognize excellence in boats, propulsion, vessel control, and marine electronics. CEO Dave Foulkes highlighted the company's focus on consumer…
Toll Brothers, a leading luxury home builder publicly traded as TOL on the NYSE, announced the upcoming launch of Toll Brothers at Sawgrass Lakes, a new luxury home community in the master-planned Babcock Ranch, Florida. The gated community will offer elegant single-family homes with lakefront views and customization options, priced from the upper …
Toll Brothers, Inc. announced the upcoming development of Toll Brothers at West Park, a new luxury single-family home community in Ashburn, Virginia. The community will offer modern home designs with 3 to 5 bedrooms, high-end amenities, and proximity to quality schools and local conveniences. Homes are priced from the upper $700,000s, targeting aff…
Felix Rosenqvist, driving with HRX gear, won the 110th Indianapolis 500 by the closest margin in race history, marking a significant milestone for HRX and Holley Performance Brands. Holley acquired HRX in March 2026 to expand its Safety & Racing segment, and this victory enhances the brand’s visibility and strategic value in global motorsports mark…
Minerals Technologies Inc.'s subsidiary CETCO participated in a U.S. EPA roundtable focused on the remediation of PFAS, showcasing their proprietary FLUORO-SORB® adsorbent technology. The product is proven in removing PFAS from water and soil efficiently and cost-effectively, and CETCO's leadership engaged with top government officials to discuss i…
SBC Medical Group Holdings Incorporated announced its participation in several investor conferences throughout May and June 2026, offering presentations and one-on-one meetings to institutional investors. The company, listed on Nasdaq since 2024 and included in the Russell 3000 Index since 2025, continues its expansion in advanced healthcare servic…
VEON Ltd., via its Ukrainian subsidiary Kyivstar Group, has acquired six solar power plants in Ukraine totaling 105 MW of installed capacity for $80.8 million. This nearly ninefold expansion of Kyivstar’s solar portfolio enhances its renewable energy production to about 118 MW, supplying around 30% of its telecom electricity consumption. The firm p…
Kyivstar Group Ltd., a Nasdaq-listed Ukrainian digital operator, has acquired six solar power plants in the Lviv region with a total capacity of 105 MW for approximately $80.8 million. This acquisition boosts Kyivstar’s renewable energy generation capacity to 118 MW, covering around 30% of its annual electricity consumption and strengthening its op…
EquipmentShare.com Inc, a leading construction equipment rental and connected jobsite technology provider, will present at the Keybanc Capital Markets Industrials & Basic Materials Conference on May 28, 2026. The company aims to highlight its innovative platforms and industry transformation initiatives.
Alaunos Therapeutics announced encouraging results from two non-GLP diet-induced obese mouse studies with their oral small-molecule candidate, ALN1003. The compound demonstrated consistent improvements across multiple metabolic disease markers including reductions in body weight and fat mass, enhanced insulin sensitivity, improved adipose endocrine…
BioRestorative Therapies, Inc. has completed dosing in its fully enrolled Phase 2 clinical trial for BRTX-100, an autologous stem cell therapy targeting chronic lumbar disc disease. The randomized, double-blind, sham-controlled study treated 99 patients and is now advancing to blinded follow-up, with topline safety and efficacy data expected in Q2 …
